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The Id (inhibitor of DNA binding or inhibitor of differentiation)
helix–loop–helix proteins are involved in the regulation of cell
growth, differentiation and cancer. The fact that the molecular
mechanisms of liver regeneration are not completely understood
prompted us to study the fate of Id2 in proliferating liver. Id2
increases in liver regeneration after partial hepatectomy, following
the early induction of its gene. Co-immunoprecipitation shows
that Id2 forms a complex with E2F4, p130 and mSin3A in qui-
escent liver and all these components are present at the c-myc
promoter as shown using ChIP (chromatin immunoprecipitation).
Activation of c-myc during hepatocyte priming (G0–G1 transition)
correlates with the dissociation of Id2 and HDAC (histone de-
acetylase), albeit p130 remains bound at least until 6 h. Moreover,
as the G0–G1 transition progresses, Id2 and HDAC again bind the
c-myc promoter concomitantly with the repression of this gene.
The time course of c-myc binding to the Id2 promoter, as deter-
mined by ChIP assays is compatible with a role of the oncoprotein
as a transcriptional inducer of Id2 in liver regeneration. Immuno-
histochemical analysis shows that Id2 also increases in pro-
liferating hepatocytes after bile duct ligation. In this case, the pat-
tern of Id2 presence in the c-myc promoter parallels that found in
regenerating liver. Our results may suggest a control role for Id2
in hepatocyte priming, through a p130 dissociation-independent
regulation of c-myc.
Key words: cell cycle, c-myc, E2F, histone deacetylase, Id2, liver
regeneration.
INTRODUCTION
The Id (inhibitor of DNA binding or inhibitor of differentiation)
helix–loop–helix protein family plays a central role in the regu-
lation of cell growth and differentiation in many mammalian
tissues [1,2]. Four members of this family, Id1–Id4, have been
identified. The first role described for them was their binding to an-
other group of basic helix–loop–helix transcription factors, block-
ing their association with DNA [3,4]. Although this association
may result in the inhibition of cell differentiation (reviewed in
[5,6]), the roles of Id proteins in regulating cell growth are far more
complicated than originally thought. Id proteins also associate
with other factors involved in cell-cycle regulation, for instance
the members of the pRb (retinoblastoma protein) family, key fac-
tors in the control of the G1–S-phase transition.
Several tumour cell lines, as well as some primary human tu-
mours, have been shown to express Id genes in a deregulated
manner [7]. However, Id2, but not Id1 or Id3, associate with the
hypophosphorylated forms of the pocket proteins and disrupt their
antiproliferative effects [8].
To investigate further the role of Id2 proteins in cell prolifer-
ation, the selection of an appropriate biological model is of cru-
cial importance. Liver regeneration is a highly regulated process of
tissue repair and replacement involving proliferation of different
liver cell populations [9,10]. This process, involved in the res-
ponse and defence against toxic insults or viral infections, is of
outstanding importance because of the capacity of the liver to
regulate its own growth and mass, and it plays a crucial role in de-
generative processes such as liver cirrhosis [9,11]. Liver regener-
ation can be experimentally induced by PH (partial hepatectomy),
the surgical removal of ∼70% of the liver [12]. This triggers the
proliferation of the remaining parenchyma cells that divide once
or twice, to rapidly restore the liver mass before returning to
quiescence [9,10]. This behaviour is possible because the hepato-
cytes have a very high replication capacity, comparable with or
exceeding that of precursor cells of proliferating tissues [13].
Much effort has been dedicated to understanding the molecular
events that trigger liver regeneration. The role of growth factors in
the mitogenic response of hepatocytes after PH has been clearly
established [9,14]. Nevertheless, quiescent hepatocytes in normal
liver do not respond to proliferating stimuli unless primed [15].
It is accepted that priming corresponds to the G0–G1 transition
[9]. The ultimate molecular mechanisms responsible for this
process are not yet fully understood, although using a microarray
methodology, Locker et al. [16] have identified 54 immediate-
early genes up-regulated during priming.
In the present study, we analysed the expression of Id2 gene in
regenerating rat liver after PH. As one of the genes that is under the
control of pocket proteins is c-myc, we also investigated the pos-
sible relation between Id2 and hepatic c-myc induction. The fact
that c-myc, an essential regulator of the G0–G1 transition [17,18],
is one of the immediate-early genes induced after PH [9,16] adds
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an additional interest to the present study. Our results suggest
a role for Id2 protein in the control of hepatocyte priming and
provide new insights into the chromatin-associated mechanisms
involved in the induction of c-myc promoter during liver re-
generation.
EXPERIMENTAL
Animals
Male pathogen-free Wistar rats (220–260 g) were held in groups
of two in cages at 22 ◦C with a 12 h light/12 h dark cycle and
fed ad libitum with free access to water. Animals were cared for
and handled in conformance with EEC guidelines [18a]. For PH,
the two anterior lobes were removed under anaesthesia using the
method of Higgins and Anderson [12] and for BDL (bile duct
ligation) model, animals were bile duct ligated according to
Kontouras et al. [19]. Animals were killed 28 days after surgery
under anaesthesia and the liver was quickly removed. The study
was approved by the Research Committee of the University of
Valencia.
RT (reverse transcriptase)–PCR studies
Total RNA from rat liver was isolated using the guanidinium thio-
cyanate method [20]. Aliquots of 2 µg were reverse-transcribed
using SuperScript II (GibcoBRL) and subsequently amplified by
PCR using AmpliTaq DNA polymerase (Applied Biosystems).
The primers used for the different genes studied were 5′-AC-
GAGCAGCATGAAAGCCTT-3′ and 5′-AGGATGCTGATGT-
CCGTGTTC-3′ for Id2, and 5′-ACCTCGACTACGACTCGG-
TG-3′ and 5′-AGAAGCCGCTCCACATACAG-3′ for c-myc. 18 S
rRNA was simultaneously amplified using the QuantumRNA
18 S Internal Standards (Ambion) as internal loading control.
Reactions were resolved using 2% agarose gel electrophoresis,
stained with ethidium bromide and quantified using the
GeneGenius System and the Gene Tools analysis software
(Syngene).
Real-time quantitative PCR was performed using double-
stranded DNA-binding dye Syber Green PCR Master Mix in
an ABI GeneAmp 7000 Sequence Detection System (Applied
Biosystems). Each reaction was carried out in triplicate for two
series of animals, and melting curves were constructed, using
Dissociation Curves Software (Applied Biosystems), to ensure
that only a single product was amplified. As a quantitative control,
18 S rRNA was also analysed.
Immunoblot analysis
Liver was homogenized in 10 ml of ice-cold RIPA buffer
(1.85 mM NaH2PO4, 8.4 mM Na2HPO4, pH 7.9, 0.1 M NaCl,
12 mM deoxycholate, 0.1% SDS, 1% Triton X-100 and 0.5%
NaN3) per gram of tissue in the presence of protease inhibitors
(Sigma). The homogenate was ultracentrifuged at 50000 rev./min
for 45 min in an OptimaTM Beckman–Coulter centrifuge using
an MLA-130 fixed-angle rotor. Equal amounts of protein were
subjected to SDS/10% PAGE and transferred on to nitrocellulose
membranes. Id2 was detected by using the corresponding antibody
(Santa Cruz sc-489) and secondary horseradish-peroxidase-con-
jugated antibody. Blots were developed by enhanced chemi-
luminescence (DuPont). The loading of the gels was checked
with an antibody specific for β-actin.
Immunohistochemical detection of Id2
Sections (5 µm thick) of paraffin-embedded liver were hydrated
and pre-treated with EDTA pH 8. Sections were incubated with
3% H2O2 for 20 min to inhibit endogenous peroxidase and then
with normal pig serum (10% in PBS and 0.1% BSA) for
30 min. Incubation with primary antibody (diluted 1:500) (Zymed
Laboratories) was performed overnight at 4 ◦C. Sections were
incubated with secondary antibody, pig anti-rabbit (Dako-
Cytomation), diluted 1:200 for 1 h at room temperature (25 ◦C),
and then with a visualization reagent (ABComplex/horseradish
peroxidase; DakoCytomation) for 25 min. Positive reactions were
detected with diaminobenzidine.
Co-immunoprecipitation
Liver tissues (2 g) were washed twice with 10 ml of cold PBS,
pH 7.4, and immersed in 8 ml of PBS supplemented with 2 µl/ml
protease inhibitor and 2 µl/ml each of phosphatase inhibitor
cocktails I and II (Sigma). Tissues were disrupted with a Dounce
homogenizer and centrifuged at 1500 g for 5 min. The pellets were
resuspended in 3 ml of cell lysis buffer (5 mM Hepes, pH 8.0,
85 mM KCl and 0.5% Nonidet P40) supplemented with pro-
tease and phosphatase inhibitors as above, incubated on ice for
15 min and centrifuged at 3500 g for 5 min to pellet the nuclei. The
nuclei were resuspended in 3 ml of nuclear lysis buffer (1 × PBS,
pH 7.4, 1% Nonidet P40, 0.5% sodium deoxycholate and 0.1%
SDS) supplemented with the abovementioned protease and phos-
phatase inhibitor cocktails. The nuclear extract was fractionated
into aliquots containing 1 mg of protein each.
Co-immunoprecipitation was performed by adding 4 µg of the
corresponding antibodies against Id2 (sc-489) E2F4 (sc-866),
p130 (sc-317) and mSin3A (sc-994) (Santa Cruz) to each aliquot
and incubating overnight at 4 ◦C in a rotating plate. Controls with
a non-related antibody (against Arabidopsis thaliana amidase,
provided by Dr G. Rı´os, Departamento de Bioquı´mica y Biologı´a
Molecular, Universidad de Vale`ncia) and without antibody were
carried out.
Immunocomplexes were captured with protein immunopreci-
pitation matrix (ExactaCruz F, sc-45043; Santa Cruz) for 4 h,
and the pellets were washed three times in protease- and phos-
phatase-inhibitor-supplemented nuclear lysis buffer. Protein com-
plexes were eluted in Laemmli’s loading buffer and subjected
to Western blotting analysis using horseradish-peroxidase-con-
jugated antibody probe (ExactaCruz F sc-45043) and ECL®
(enhanced chemiluminescence) advance Western blotting detec-
tion kit (Amersham Biosciences).
ChIP (chromatin immunoprecipitation) assay and RNA pol-ChIP
Cross-linking of chromatin, ChIP and RNA pol-ChIP procedures
were performed using the method of Sandoval et al. [21]. Briefly,
isolated nuclei from formaldehyde-cross-linked livers were lysed
and cross-linked chromatin was sonicated to yield fragments of
∼500 bp. Diluted soluble chromatin fragments were pre-cleared
with blocked Protein A/G–Sepharose, to discard non-specifically
bound chromatin fragments. Immunofractionation of complexes
was carried out by adding 2 µg of the corresponding antibodies
against Id2, E2F4, P130, mSin3A, RNA pol II (sc-899) and
c-myc (sc-764) (Santa Cruz) to aliquots containing 50 µg of DNA
each. The immunocomplexes were recovered by centrifugation at
13500 g for 1 min after adding blocked Protein A/G–Sepharose
and washing extensively. Immunoselected chromatin was
eluted and the formaldehyde cross-linking was reverted. The
DNA from all samples was purified with a PCR purification
kit (Qiagen), and used for PCR analysis, which was carried
out with the following primers: c-myc (promoter) 5′-GTGCCC-
CTCCCGAGTTCC-3′ and 5′-GCGACTCCGGATCCCTCC-3′;
c-myc (coding region) 5′-ACAACCGCAAATGCTCCAGC-3′
and 5′-TCCGGTCAGTTTATGCACCAAG-3′; Id2 (promoter)
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Figure 1 Expression of Id2 and c-myc genes during liver regeneration
Steady-state levels of Id2 (A) and c-myc (B) mRNA over time after PH, as shown by
semi-quantitative and quantitative RT–PCR. In the latter instance, histograms give the data
for controls (t = 0) and after PH, corrected relative to the level of 18 S rRNA. The value of control
was arbitrarily set to 1. Samples were run in triplicate for two independent series of animals.
Results are means +− S.D. The melting curves are also shown to check that a single specific
amplicon is being generated.
5′-ACGGGCATTGGCTGCGAACG-3′ and 5′-GAGGAAAGG-
CCGGGAGGGAG-3′; Id2 (coding region) 5′-ACAAGAAG-
GTGACCAAGATGGAA-3′ and 5′-GCGATCTGCAGGTCCA-
AGAT-3′; α-actin (promoter) 5′-AGGGACTCTAGTGCCCAA-
CACC-3′ and 5′-CCCACCTCCACCCTACCTGC-3′; α-actin
(coding region) 5′-AGGATTCCTACGTGGGCGAC-3′ and 5′-
TAGAGAGACAGCACCGCCTG-3′; β-actin (coding region)
5′-TTCAACACCCCAGCCATGT-3′ and 5′-GTGGTACGACCA-
GAGGCATACA-3′.
RESULTS
Id2 gene is up-regulated during liver regeneration
The expression of the Id2 gene was first evaluated by both semi-
quantitative and quantitative RT–PCR analyses. The steady-state
levels of Id2 mRNA were significantly increased early after PH,
reaching a maximum at approx. 1 h and returning to control
values by 6 h (Figure 1A). This peak of Id2 expression occurs
during the hepatocyte priming phase (G0–G1 transition). A second,
yet flatter, peak of Id2 expression occurs later during regeneration.
In accordance with the results of other workers (see, for instance,
[22]), c-myc, apart from being an immediate-early gene [9], dis-
plays an expression pattern similar to that of Id2 and its expression
Figure 2 Complex-associated forms of Id2 in the nuclei of quiescent liver
Nuclear extracts were immunoprecipitated with antibodies against p130 (α-p130), Id2 (α-Id2),
mSin3A (α-sin3A) and E2F4 (α-E2F4). The proteins in the immunoprecipitates were subjected
to electrophoresis (8 % PAGE for p130 and 15 % PAGE for Id2) and analysed by Western blotting
using the antibodies against p130 (B, upper panel) and Id2 (B, lower panel). To assess the
specificity of p130 and Id2 antibodies, the input sample (5 % of total nuclear aliquot) was also
analysed by Western blotting (A). Molecular masses (MW) are given in kDa. As a control, a sample
was treated in the immunoprecipitation protocol with a non-related antibody (NR Ab). A fur-
ther control was carried out in the experiment without added antibody (No Ab).
is resumed during G1–S transition (Figure 1B). Western blot ex-
periments demonstrate that the level of Id2, which is low in qui-
escent cells, increases soon after PH, following the activation of
Id2 gene transcription (results not shown).
Id2 is present in the c-myc promoter in quiescent cells
Id2 is able to bind to pocket proteins regulating their function
[23,24]. Specifically, the low amount of Id2 found in quiescent
fibroblasts is mainly bound to p130 [25]. The co-immuno-
precipitation experiment shown in Figure 2 demonstrated that this
binding also occur in quiescent liver cells, where p130 and Id2
form a complex with E2F4 and mSin3A [an important component
of a HDAC (histone deacetylase) repressor complex]. Massague´
and colleagues have found that complexes between E2F4/5 and
the pocket protein p107 are essential for c-myc repression in
keratinocytes [26]. As the pocket proteins inhibit the action of
E2F by recruiting HDACs [27–29], a mechanism that is also in-
volved in placing keratinocytes in a quiescent state [30], the
hypothesis that Id2 is involved in liver proliferation by regulating
c-myc gene expression through a histone acetylation-dependent
mechanism was a plausible one. To check the potential role of
these factors in the regulation of c-myc promoter, we carried out
the ChIP assay shown in Figure 3. Id2 is present in the c-myc pro-
moter in quiescent cells, together with E2F4, p130 and mSin3A
(Figure 3A). It is worth noting that, to the best of our knowledge,
this is the first time that Id2 has been shown to be bound to DNA,
although, most likely, on the basis of the current knowledge, the
binding was not a direct one. The same samples employed for
the ChIP assay were used for RNA pol-ChIP [21]. Briefly, this
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Figure 3 In vivo binding of several factors to the c-myc gene at different
times after PH
(A) Analysis of the c-myc promoter by ChIP assay with antibodies against E2F4 (α-E2F4),
p130 (α-p130), mSin3A (α-mSin3A) and Id2 (α-Id2). For each time, a sample of total
chromatin (input) was included in the PCR. No Ab, no antibody. (B) PCR products obtained
with oligonucleotides specific for α-actin gene promoter, included as a negative control.
(C) RNA pol-ChIP analysis of the c-myc transcription. The same cross-linked chromatin
samples used in (A) and (B) were immunoprecipitated with an anti-(RNA pol II) antibody, and
the immunoprecipitates were analysed by PCR using specific primers from the c-myc coding
region. The presence of RNA polymerase in these regions is taken as a measure of actual
transcription. As negative and positive controls, the PCR analysis of the immunoprecipitates
with primers from the α- and β-actin gene coding regions respectively were also added.
technique consists of using the chromatin immunoprecipitated
with an anti-(RNA pol II) antibody for the PCR detection of
the coding region of the desired gene. Therefore it provides an
excellent internal control of real-time transcription. At 30 min
after PH, c-myc is actively transcribed (Figure 3C) and, at this
time, Id2 and mSin3A dissociated from the c-myc promoter
(Figure 3A). A further comparison of Figures 3(A) and 3(C)
reveals that, at 6 h after PH, when the transcription of c-myc passes
through a minimum, Id2 and mSin3A again appear to be bound
to the promoter. The p130–E2F4 complex remained attached
along the whole priming period, independently of the transcrip-
tional state of c-myc.
The c-myc oncoprotein is present in the rat Id2 promoter
during hepatocyte priming
Lasorella et al. [25] reported that the overexpression of Id2 in
human neuroblastoma cells is associated with the presence of extra
copies of c-myc and that c-myc and N-myc activate the expression
of Id2 in fibroblasts and neuroblastoma cells respectively. More-
over, c-myc directly induces the expression of Id2 in fibroblasts
by binding to its consensus sequences in the promoter of the
human gene. To ascertain whether c-myc could also up-regulate
Id2 during liver regeneration, we searched for c-myc consensus
binding sequences in the rat Id2 promoter to find that it contains
a cluster of E-boxes susceptible to binding c-myc, as the human
and mouse promoters do [25]. In quiescent liver, c-myc is not sub-
stantially bound to the Id2 promoter, but the oncoprotein is
recruited soon after PH (Figure 4A). Its presence is clear at 30 min
Figure 4 Analysis of the Id2 gene for binding of c-myc and RNA polymerase
in vivo to the promoter and for transcription after PH
Immunoprecipitation of formaldehyde-cross-linked chromatin was carried out in control rat liver
and at several times after PH, by using antibodies against c-myc (α-c-myc) (A) or RNA pol II
(α-RNA pol II) (B) and (C). Immunoprecipitates were analysed by PCR with primers specific
for the Id2 promoter (A and B) or for the Id2 coding region, to show actual transcription of the
gene (RNA pol-ChIP assay; C). In the right-hand panel of (A), the PCR products obtained with
oligonucleotides specific for α-actin gene promoter were included as a negative control. No Ab,
no antibody.
and passes through a maximum at 1 h, concomitant with the early
activation of Id2 gene expression (compare Figures 4A and 4C).
Interestingly, RNA pol II is bound to Id2 promoter even in control
liver, when active transcription has not yet started (Figure 4B).
This shows that Id2 gene ranks among those in which RNA poly-
merase is paused at the promoter, waiting for the signal to initiate
transcription. On the other hand, comparison of the RNA pol-
ChIP analyses of Figures 3(C) and 4(C) shows that transcription
of Id2 is somewhat delayed relative to the transcription of c-myc.
Id2 is up-regulated in BDL
Cirrhosis, which is often regarded as a pre-cancerous condition
[31–33], shares some mechanistic aspects with liver regeneration.
This fact, together with the Id2 overexpression described in dif-
ferent primary human tumours [8], led us to evaluate the express-
ion of the Id2 gene in another model of hepatocyte proliferation,
namely BDL rats, which are often regarded as an experimental
model of cirrhosis [19]. After 28 days of BDL, the steady-state
levels of Id2 mRNA, determined by RT–PCR, were significantly
increased in BDL rat liver (Figure 5A), as those of c-myc are
(Figure 5B). The Id2 mRNA was actually translated in liver, as
confirmed by Western blotting (Figure 5C). Moreover, immuno-
histochemical analysis allowed us to confirm that Id2 actually
accumulates not only in bile duct cells, but also in hepatocytes
(Figures 5D and 5E), where it localizes both to nuclei and
cytoplasm. PCNA (proliferating-cell nuclear antigen) analyses
showed that a significant proportion of hepatocytes are prolifer-
ating in BDL rats (results not shown). These results validate the
model used in our experiments.
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Figure 5 Expression of the Id2 gene in rat liver 28 days after BDL
(A) RT–PCR analyses of Id2 mRNA for three representative liver samples obtained 28 days
after BDL. C, control. (B) RT–PCR analyses of c-myc mRNA in the same samples as in (A).
(C) Western blot analysis of Id2 protein at 28 days after BDL, β-actin was used as loading
control. (D) Immunohistochemical localization of Id2 in control rat liver. See the Experimental
section for experimental details. (E) Immunohistochemical localization of Id2 in rat liver 28 days
after BDL.
Figure 6 mSin3A and Id2 are released in vivo from the c-myc promoter in
cirrhotic rats when the gene is being transcribed
The experiment was conducted as in Figure 3, with samples from rat cirrhotic liver at 28 days
after BDL. (A) ChIP analysis was carried out with the antibodies indicated over the PCR results
in control and cirrhotic rats. The primers were specific for c-myc promoter. (B) Real-time RNA
pol-ChIP analysis of c-myc transcription in normal and cirrhotic rats. An antibody against
RNA pol II (α-RNA pol II) was used for immunoprecipitation of chromatin, and the bound DNA
was analysed with primers from the third exon of the c-myc gene. No Ab, no antibody.
Finally, we studied the binding of factors to the c-myc promoter
in BDL-rats. Figure 6(A) shows that Id2 and mSin3A are absent
from the c-myc promoter, whereas E2F4 and p130 are present,
in a manner similar to that observed in hepatocyte priming.
This situation correlated with the presence of RNA pol II in the
coding region of c-myc (Figure 6B). Therefore many Id2-related
characteristics are shared by proliferating hepatocytes, irrespec-
tive of the cause that triggers proliferation.
DISCUSSION
The events that trigger the proliferation of the quiescent hepato-
cytes after PH are complex and remain unknown in many aspects.
The simple infusion of growth factors such as TGFα (transforming
growth factor α) or EGF (epidermal growth factor) into the
normal liver does not result in increased DNA synthesis, which
actually takes place if the infusion is preceded by PH [34]. There-
fore hepatocyte proliferation in vivo requires an initial priming
stimulus [9], such as PH, which allows the cells to exit from G0.
Although their molecular aspects are not yet fully understood, it
is known that hepatocyte priming is marked by the induction of
c-myc gene expression [35].
Our results show for the first time that Id2 gene expression is up-
regulated in rats immediately after PH. Togo et al. [36], working
with DNA microarrays, have reported a discrete increase of Id2
transcripts 6 h after PH in mice. Nevertheless, both the quantitative
PCR of Figure 1(A) and the RNA pol-ChIP of Figure 4(C) clearly
show that the level of Id2 transcription in rats reaches a maximum
at approx. 1 h after PH. To date, the central role assigned to Id2
in promoting dedifferentiation and cell proliferation consists in
the reversal of the pRb-mediated cell-cycle arrest [23], which
in our model would allow the hepatocyte to progress from G1-
to S-phase. However, the data presented here suggest another
earlier role for Id2 in liver regeneration, namely in the hepatocyte
priming, or G0–G1 transition.
The promoter of Id2 is a target for c-myc in many cell types
[37–40] and Lasorella et al. [25] have shown that c-myc binding
activates Id2 in fibroblasts. The timing of c-myc binding to the
Id2 promoter (Figure 4) also agrees with this activating role in
regenerating liver, especially during hepatocyte priming. Interest-
ingly, the ChIP experiments of Figure 3 show that Id2 protein,
bound to the c-myc promoter in quiescent hepatocytes, leaves
it when the gene is expressed. This removal also occurs during
hepatocyte priming, concomitantly with the parting of the HDAC
complex, and does not result in the displacement of p130
(Figure 3). It is well established that the sequestering of the
non-phosphorylated form of the pocket proteins by Id2 results
in the progression from G1 to S-phase [41]. This action of Id2 is
possible because a second peak of Id2 expression occurs at late G1,
for instance, in fibroblasts [42]. During liver regeneration, there is
also a second peak of Id2 expression at 24 h (Figures 1A and 4C),
which may be involved in the G1–S progression, but the earlier
events observed here are markedly different. In a recent work,
Russell et al. [43] have shown that Id2 prevents tumour formation
in the intestinal epithelium. This result would be explained if
Id2 actually were inhibitory of the expression of c-myc in vivo,
as our results might indicate. If it were, this unexpected link
between Id2 and c-myc would establish an autoregulatory loop be-
tween both proteins that may contribute to the exquisite regu-
lation of liver proliferation.
The binding of Id2 to the c-myc promoter is probably indirect
as it seems to be recruited to the E2F site through p130. The
simultaneous presence of all these factors (Figure 3) shows that
binding of E2F and Id2 to pocket proteins is, most likely, not
mutually exclusive. On the other hand, the binding of Id2 seems
to depend on factors other than its concentration, as the pattern
of promoter binding (Figure 3A) does not follow Id2 expression
(Figure 1A). The lack of correlation between Id2 concentration
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and binding to the c-myc promoter also occurs in BDL rats (com-
pare Figures 5D and 6A). It should be kept in mind that the low
amounts of Id2 present in quiescent liver are complexed with p130
(Figure 2), as it occurs in quiescent fibroblasts [25], and that the
complex containing these components, together with E2F4 and
mSin3A, is bound to the c-myc promoter (Figure 3). Interestingly,
the early induction of c-myc during hepatocyte priming occurs
concomitantly with the removal of both Id2 and the HDAC com-
ponent mSin3A, while E2F4 and p130 remain bound to the pro-
moter (Figure 3). So, the role of Id2 protein in hepatocyte priming
seems to be independent of p130 removal, in contrast with its later
role in the G1–S transition [41].
Therefore the control of c-myc transcription during priming
is independent of pocket protein displacement, although it may
depend on chromatin structure, because activation is concomitant
with the removal of the deacetylase complex. The mechanism by
which the deacetylases are released during hepatocyte priming
remains obscure and may involve other factors, such as NF-κB
(nuclear factor κB), a key factor in the activation of c-myc
and other immediate-early genes during liver regeneration [44].
On the other hand, the persistence of pocket proteins does not
mean that they are ineffective in the priming process. For example,
in the growth arrest during macrophage terminal differentiation,
i.e. in the exit from the cell cycle to enter G0, Ets (E twenty-
six) factors are replaced in the c-myc promoter by the repressor
METS (mitogenic Ets transcriptional suppressor), which, in
turn, recruits a Sin3A–deacetylase–corepressor complex and the
interplay between METS and E2F–pRb complexes can provide
a mechanism to exit from the cell cycle [45]. The mechanisms
for interaction between METS and E2F–pRb are not known, but
Id2 protein might be involved in them owing to its capability
of binding pocket proteins as well as repressor complexes. Ob-
viously, more research is needed to ascertain the existence of any
of these mechanisms. The use of Id2-knockout mice, in which
some aspects of the mechanisms of lactation have been studied
[46], may be of great interest to clear up the exact role of Id2 in
c-myc control and in hepatocyte priming.
Finally, we wish to emphasize that the occupancy of the c-myc
promoter shows an obvious correlation between cirrhotic liver and
the priming phase after PH. Cirrhosis constitutes a risk factor for
HCC (hepatocellular carcinoma) [47] although the mechanisms
for the cirrhosis–HCC progression are still poorly understood.
The expression of c-myc in human and animal cirrhotic livers is
generally considered to precede the formation of HCC [48–50],
so, in view of our results, it could be hypothesized that cirrhotic
hepatocytes are in a certain sense ‘primed’ for proliferation. It is
desirable to explore this question further, as the feasibility of the
ChIP assays might make them a useful technique of prognostic
value in evaluating the risks of cirrhosis to HCC transition.
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